Benton Susan 4
4 · Ocuphire Pharma, Inc. · Filed Jun 8, 2023
Insider Transaction Report
Form 4
Benton Susan
Director
Transactions
- Award
Common Stock
2023-06-06+10,976→ 79,462 total - Award
Stock Option
2023-06-06+9,639→ 9,639 totalExercise: $3.83Exp: 2033-06-05→ Common Stock (9,639 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
- [F2]Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.